Get startedLog in
    Picture of CERo Therapeutics Holdings logo

    CERO — CERo Therapeutics Holdings News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Trial Of Cer-1236 In Aml

    Picture of CERo Therapeutics Holdings logoCERo Therapeutics Holdings
    17/12/2025 13:30
    Dec 17 (Reuters) - CERo Therapeutics Holdings Inc CERO.PK:

CERO THERAPEUTICS PROVIDES CLINICAL UPDATE ON PHASE 1 CLINICAL TRIAL OF CER-1236 IN AML (CERTAINT-1)

Source text: ID:nGNX54NB5b

Further company coverage: CERO.PK

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on CERo Therapeutics Holdings

    See all news